Pediatric chemo regimen cuts mortality in ALL patients under 40

04/23/2012 |

Israeli researchers reported in the American Journal of Hematology that teens and young adults with acute lymphoblastic leukemia who were given pediatric-inspired induction chemotherapy drugs had lower all-cause mortality and relapse rates than the group receiving traditional adult chemotherapy regimens. They also found that the pediatric-inspired chemotherapy group had greater remission and event-free survival rates compared with the other group.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA